Ivermectin Quietly Added To Nih Website For Treating Covid

On Sep 1st, some people noticed that the National Institute of Health (NIH) quietly added Ivermectin alongside Remdesivir and Paxlovid which were actively pushed by the institute, for treating Covid or the CCP virus on its website. This is the first time that Ivermectin is included as a treatment of the CCP virus. 

 But NIH also suggests “the panel recommends against the use of Ivermectin for the treatment of CCP virus, except in clinical trials.” Some people think that the institute needs to cooperate with the previous emergency authorization of the CCP virus vaccine until May 2023, that is after Pfizer completes its phase 3 of mRNA vaccine clinical trial. So they have to keep denying efficacy of Ivermectin against the virus. Otherwise the emergency use authorization of vaccine would be revoked. But as of now, Ivermectin is available over the counter in at least 4 states, including Tennessee and New Hampshire. Several other state legislators have also proposed a number of bills in an effort to use Ivermectin to treat the CCP virus patients in a more convenient and efficient manner.

 Analysts said NIH’s action on its website was incomprehensible and might be related to Fauci’s resignation as the director of the National Institute of Allergy and Infectious Diseases (NIAID) and severe other roles as of December. The larger context is that the humanity will have to confront the catastrophe caused the CCP virus vaccine soon.